Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended
Jun. 30, 2021
Jun. 30, 2020
REVENUES    
Government contract revenue $ 131,966 $ 0
OPERATING EXPENSES    
Professional fees 583,469 564,284
Payroll and related expenses 1,016,742 436,911
General and administrative 630,068 409,223
Total operating expenses 2,230,279 1,410,418
OPERATING LOSS (2,098,313) (1,410,418)
OTHER EXPENSE    
Interest and other debt expenses 125 728
Total other expense 125 728
NET LOSS (2,098,438) (1,411,146)
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS (1,135) (863)
NET LOSS ATTRIBUTABLE TO AETHLON MEDICAL, INC. $ (2,097,303) $ (1,410,283)
BASIC AND DILUTED LOSS PER COMMON SHARE $ (0.16) $ (0.15)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING – BASIC AND DILUTED 12,828,816 9,632,977